CODX vs MRVL · rev $3.9M vs P/E 100, rev $8.19B
Co-Diagnostics, Inc. Common Stock (CODX) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. Revenue was up 42.1% from 2025-02-01 to 2026-01-31. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
CODX currently screens at market cap $31.4M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the CODX and MRVL stock pages for the full models.
Not investment advice.